Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Dagenais, Simon
Pfizer
Leveraging Real-World Data in Pharmacometrics: Augmenting Clinical Trials and Advancing Research in Understudied Populations
Location: Colorado B-D
Simon Dagenais
Favorite
Leveraging Real-World Data to Extend Adult Drug Approvals to Pediatric Populations: A Pharmacometric Approach
Location: Colorado B-D
Simon Dagenais
Favorite
Panel - Leveraging Real-World Data in Pharmacometrics: Augmenting Clinical Trials and Advancing Research in Understudied Populations
Location: Colorado B-D
Simon Dagenais
Favorite
de Witte, Wilhelmus
ESQlabs GmbH
ESQlabs: Building Scalable PBPK-QSP Models: Modularization in MoBi® for OSP Suite V12
Location: Red Rock 3
Wilhelmus de Witte
Favorite
Denney, Bill
Human Predictions, LLC
Pharmacometrics Phisticuffs 1* – Does Pharmacometrics accelerate or slow down a medicine’s path to patients?
Location: Willow Lake 3 - 5
Bill Denney
Favorite
Pharmacometrics's strategic impact in Drug Development
Location: Willow Lake 3 - 5
Bill Denney
Favorite
Derippe, Thibaud
AstraZeneca
Hands on application and examples of ChatGPT-assisted R code generation/troubleshooting, data cleaning and exploratory analysis
Location: Red Rock 6/7
Thibaud Derippe
Favorite
Introduction of the foundational components and language syntax of R
Location: Red Rock 6/7
Thibaud Derippe
Favorite
STEP Tutorial: Smarter Modeling in Pharmacometrics: Leveraging R and ChatGPT for Insight and Efficiency
Location: Red Rock 6/7
Thibaud Derippe
Favorite
Desai, Devam
Center of Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, FL
Envisioning the Future Landscape of Quantitative Pharmacology and MIDD for Next-Generation RNA Therapeutics
Location: Red Rock 8/9
Devam Desai
Favorite
Systems modelling for gene-based therapies
Location: Red Rock 8/9
Devam Desai
Favorite
Desikan, Rajat
GSK (UK)
Machine learning applied to Hepatitis B virtual patients suggests prognostic biomarker signatures for stratifying responders to standard-of-care therapies.
Location: Willow Lake 3 - 5
Rajat Desikan
Favorite
Strategies for Selecting Explanatory Variables in Exposure-Response Analysis Using Machine Learning
Location: Willow Lake 3 - 5
Rajat Desikan
Favorite
Dickinson, Gemma
Eli Lilly and Company
Accelerating a medicine's path to patients - First Registration
Location: Willow Lake 3 - 5
Gemma Dickinson
Favorite
Diderichsen, Paul
Certara USA, Inc.
Dose selection and go/no-go decisions in a second indication by leveraging published clinical trial data for drugs/classes approved in multiple indications
Location: Willow Lake 3 - 5
Paul Diderichsen
Favorite
Dykstra, Kevin
Presidents Address
Location: Colorado B-D
Kevin Dykstra
Favorite
